#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous calcification Hepato-lenticular degeneration Glioma Retinal artery occlusion Chorioretinitis Congenital hypotransferrinaemia B precursor type acute leukaemia Chronic graft versus host disease in intestine Congenital pseudarthrosis Polymyositis Frostbite Hydrocephalus Pancreatic neuroendocrine tumour Cytokine release syndrome Congenital leptin deficiency More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Trials in Disease Mantle cell lymphoma – Basic Information Inclusion body myositis – Trials in Disease Cystic fibrosis – Trials in Disease Wolfram syndrome – Treatment Advanced systemic mastocytosis – Trials in Disease Paraneoplastic neurological syndrome – Trials in Disease Breast angiosarcoma – Diagnostics Focal segmental glomerulosclerosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dotatate Phleum Pratense Pollen Extract Tusamitamab Ravtansine Pbf-999 Zetomipzomib Bosentan Omeprazole STREPTOCOCCUS VIRIDANS Repagermanium Rmc-6291 Xaluritamig Obicetrapib Metamizole Setmelanotide Bupropion Hydrochloride Empagliflozin Sildenafil Hydroxychloroquine Sulfate Ieramilimab Mannitol More therapies…

    Learn about Your Condition

    Graves' disease Herpes simplex Colour blindness Radius fracture Metabolic surgery Naevus flammeus Lymphoedema Desmoplastic melanoma Acute on chronic liver failure Cachexia Viral infection Acarodermatitis Urinary tract infection Amyotrophic lateral sclerosis C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer metastatic

  • Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Letrozole
    • Fulvestrant
    Czechia Slovakia

  • Study on Retreatment with Encorafenib and Cetuximab for Patients with BRAF V600E Mutated Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Encorafenib
    • Cetuximab
    Italy

  • Study on EO4010 Vaccine with Nivolumab and Bevacizumab for Patients with Metastatic Colorectal Cancer Who Have Already Received Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Eo2317
    • Eo2318
    • Omp10
    France Spain

  • Study Comparing Regorafenib and Regorafenib-Irinotecan Combination for Patients with Metastatic Colorectal Cancer After Standard Treatments Have Failed

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Regorafenib
    • Irinotecan
    France

  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Metastatic malignant melanoma
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Alectinib
    • Alectinib Hydrochloride
    • Cobimetinib
    Belgium Czechia France Germany Greece Hungary +5

  • Study on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Pancreatic carcinoma metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Ict01
    • Aldesleukin
    • Pembrolizumab
    France Germany
Previous Page
1 … 13 14 15 16 17 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!